You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study
|
|---|---|
| Published in |
Frontiers in oncology, October 2018
|
| DOI | 10.3389/fonc.2018.00452 |
| Pubmed ID | |
| Authors |
Cristian Scatena, Manuela Roncella, Antonello Di Paolo, Paolo Aretini, Michele Menicagli, Giovanni Fanelli, Carolina Marini, Chiara Maria Mazzanti, Matteo Ghilli, Federica Sotgia, Michael P. Lisanti, Antonio Giuseppe Naccarato |
X Demographics
The data shown below were collected from the profiles of 31 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 19% |
| Canada | 3 | 10% |
| Italy | 1 | 3% |
| Germany | 1 | 3% |
| United Kingdom | 1 | 3% |
| Switzerland | 1 | 3% |
| Kenya | 1 | 3% |
| Jordan | 1 | 3% |
| Saudi Arabia | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 15 | 48% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 26 | 84% |
| Science communicators (journalists, bloggers, editors) | 2 | 6% |
| Practitioners (doctors, other healthcare professionals) | 1 | 3% |
| Scientists | 1 | 3% |
| Unknown | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 108 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 15% |
| Student > Bachelor | 15 | 14% |
| Student > Ph. D. Student | 11 | 10% |
| Student > Master | 8 | 7% |
| Student > Doctoral Student | 6 | 6% |
| Other | 16 | 15% |
| Unknown | 36 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 24 | 22% |
| Medicine and Dentistry | 11 | 10% |
| Agricultural and Biological Sciences | 8 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 6% |
| Immunology and Microbiology | 4 | 4% |
| Other | 13 | 12% |
| Unknown | 41 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 51. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 September 2023.
All research outputs
#828,160
of 25,508,813 outputs
Outputs from Frontiers in oncology
#133
of 22,613 outputs
Outputs of similar age
#17,911
of 358,469 outputs
Outputs of similar age from Frontiers in oncology
#2
of 218 outputs
Altmetric has tracked 25,508,813 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,613 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 358,469 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 218 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.